Around 90 per cent of Gulf-based healthcare companies are positive that their business will grow in 2018, an exclusive Hanover Health survey recently revealed. Strategic communications firm Hanover spoke to 65 senior executives taking part in this year’s Arab Health congress in order to gauge the growth potential of the healthcare industry in the Middle East. Almost all respondents were “positive” or “very positive” their business would grow in 2018.
Around one third [29pc] of respondents believe an expansion of government policy will be the top growth driver for their industry, followed by an uptick in private and public government spend [27pc] and the Middle East’s ageing population [26pc].
Andrew Harrison, Managing Director of Hanover Health said: “The results of the Hanover Healthcare Business Barometer demonstrate the very real business opportunity in healthcare in the Middle East. But smart, strategic communication, coupled with global issues and regulatory expertise is needed to capitalise and catalyse business growth.”
A quarter of respondents [25pc] said regional geopolitics was a key challenge to business growth, followed closely by the increasingly competitive healthcare market [23pc]. Other potential hinderances to growth include, conversely, government policies [19pc] as well as payer focus on value and price [15pc].
Hanover launched its Middle East Health practice, and in 2017 won EMEA Healthcare Consultancy of the Year at the SABRE Awards for the second year running. Hanover Health supports clients across the healthcare industry, including pharmaceutical and medical technology companies, healthcare service providers, charities, and government bodies.